Actavis PLC

 
Find more results for Christopher B. Warner�

Officers and directors

Paul M. Bisaro
Chairman of the Board, President, Chief Executive Officer
Sigurdur Oli Olafsson
President - Actavis Pharma, Director
Robert A. Stewart
President - Global Manufacturing and Distribution
George Frederick Wilkinson
President - Actavis Global Research and Development
James C. D'Arecca
Chief Accounting Officer, Global
Patrick J. Eagan
Chief Human Resource Officer, Global
R. Todd Joyce CPA
Chief Financial Officer, Global
Charles M. Mayr
Chief Communication Officer, Global
David A. Buchen
Chief Legal Officer, Global and Secretary
Andrew L. Turner
Lead Independent Director

Address

70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2
DUBLIN, 07054
Ireland
+1-862-2617000 (Phone)

Website links

External links

Actavis PLC is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In April 2014, Aurobindo Pharma Ltd acquired certain commercial operations in Western Europe from Actavis plc. In April 2014, the Company acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand.

Related companies